Friday’s Midday Stock Update: Orexigen (OREX), Pernix Therapeutics (PTX), Anthera Pharmaceuticals (ANTH), TrovaGene (TROV), ImmunoCellular Therapeutics (IMUC)

By Carrie Williams

So far Friday, March 8, NASDAQ is up 1.45% and the S&P is up 0.07%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Orexigen (OREXResearch Report), Pernix Therapeutics (PTXResearch Report), Anthera Pharmaceuticals (ANTHResearch Report), TrovaGene (TROVResearch Report) and ImmunoCellular Therapeutics (IMUCResearch Report).

Orexigen is up 140% in midday trading to $0.01. Shares opened today at $0.01. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

Pernix Therapeutics is up 37.5% in midday trading to $0.11. Shares opened today at $0.08. The company has a 52-week low of $0.07 and a 52-week high of $0.00.

Anthera Pharmaceuticals is up 21.1% in midday trading to $0.10. Shares opened today at $0.08. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

See today’s analyst top recommended stocks >>

TrovaGene is down -20.34% in midday trading to $7.09. Shares opened today at $8.90. The company has a 52-week low of $2.54 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $14.00, marking a 57.30% potential upside from current levels. In a report released today, Noble Financial analyst Ahu Demir reiterated a Buy rating on TROV, with a price target of $20, which implies an upside of 125% from current levels.

See today’s analyst top recommended stocks >>

ImmunoCellular Therapeutics is up 17.92% in midday trading to $0.03. Shares opened today at $0.02. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Trending Stocks Based on Insider Activity >>